European Regimen Accelerator for Tuberculosis
Grant Agreement no. 853989 — ERA4TB
era4tb.org
One week left to register for our webinar on "Modelling the Future: Early-Phase Development and HTA Insights from TBAJ-587".
📅 Date: 26 November 2025; 11am-12pm (GMT)
Register here: meetnice.zoom.us/webinar/regi...
One week left to register for our webinar on "Modelling the Future: Early-Phase Development and HTA Insights from TBAJ-587".
📅 Date: 26 November 2025; 11am-12pm (GMT)
Register here: meetnice.zoom.us/webinar/regi...
Learn more through a webinar on 21 October 2025.
👉 Research paper: https://bit.ly/4q7jIKE
👉 Webinar registration: https://bit.ly/3VN3Sa5
Learn more through a webinar on 21 October 2025.
👉 Research paper: https://bit.ly/4q7jIKE
👉 Webinar registration: https://bit.ly/3VN3Sa5
🕒 Only one day left!
ERA4TB, in collaboration with @NICEComms and the @WHO, are proud to introduce our speakers for tomorrow's webinar!
Register to save your spot: tinyurl.com/ERA4TB
🕒 Only one day left!
ERA4TB, in collaboration with @NICEComms and the @WHO, are proud to introduce our speakers for tomorrow's webinar!
Register to save your spot: tinyurl.com/ERA4TB
🕒 Only two days left! Do not miss our online webinar, focusing on tackling anti-microbial resistance through policy and partnerships
Register here: tinyurl.com/ERA4TB
🕒 Only two days left! Do not miss our online webinar, focusing on tackling anti-microbial resistance through policy and partnerships
Register here: tinyurl.com/ERA4TB
One week left to register for our webinar on 'Innovating Access: Tackling Anti-Microbial Resistance Through Policy'.
📅 Date: 8 October 2025; 1-2pm UK time
💻 Register here: tinyurl.com/ERA4TB
One week left to register for our webinar on 'Innovating Access: Tackling Anti-Microbial Resistance Through Policy'.
📅 Date: 8 October 2025; 1-2pm UK time
💻 Register here: tinyurl.com/ERA4TB
#ERA4TB Consortium Members from University of Pavia, hosted an interactive stand at Sharper Night - European Researchers' Night (2025).
#ERA4TB Consortium Members from University of Pavia, hosted an interactive stand at Sharper Night - European Researchers' Night (2025).
How can health systems respond to #AMR through innovation & evidence-based policy? 🌍✨
🗓️ 8 Oct 2025 | 1–2pm UK | 2–3pm CEST
🎙️ Speakers from NICE & WHO
👉 Register: tinyurl.com/ERA4TB
@amr-accelerator.bsky.social @amr-accelerator.bsky.social @tballiance.bsky.social
How can health systems respond to #AMR through innovation & evidence-based policy? 🌍✨
🗓️ 8 Oct 2025 | 1–2pm UK | 2–3pm CEST
🎙️ Speakers from NICE & WHO
👉 Register: tinyurl.com/ERA4TB
@amr-accelerator.bsky.social @amr-accelerator.bsky.social @tballiance.bsky.social
How can health systems respond to #AMR through innovation & evidence-based policy? 🌍
Join our ERA4TB webinar
🗓️ 8 Oct 2025 | 1–2pm UK | 2–3pm CEST
🎙️ Speakers from @NICEComms & @WHO
👉 Register: tinyurl.com/ERA4TB
@amr-accelerator.bsky.social @who.int @nicecomms.bsky.social
How can health systems respond to #AMR through innovation & evidence-based policy? 🌍
Join our ERA4TB webinar
🗓️ 8 Oct 2025 | 1–2pm UK | 2–3pm CEST
🎙️ Speakers from @NICEComms & @WHO
👉 Register: tinyurl.com/ERA4TB
@amr-accelerator.bsky.social @who.int @nicecomms.bsky.social
👉 𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: bit.ly/3VJJJBw
👉 𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: bit.ly/3VJJJBw
#ERA4TB #TB #TranslationalResearch #DrugDevelopment
#ERA4TB #TB #TranslationalResearch #DrugDevelopment
Diana shared how ERA4TB has built a robust translational platform to accelerate the progression of anti-TB drug candidates and combinatorial regimens.
#TBSky #TBResearch #DrugDevelopment
Diana shared how ERA4TB has built a robust translational platform to accelerate the progression of anti-TB drug candidates and combinatorial regimens.
#TBSky #TBResearch #DrugDevelopment
#TBSky #TBResearch
#TBSky #TBResearch
www.page-meeting.org/default.asp?...
#TBSky #TBResearch #Tuberculosis
www.page-meeting.org/default.asp?...
#TBSky #TBResearch #Tuberculosis
🔬Keynotes on antimicrobial resistance & new TB medicine development
💊Progress on TBAJ-587
🔍Novel drug testing approaches & mechanisms of action
@ihieurope.bsky.social @amr-accelerator.bsky.social @www.unizar.es
🔬Keynotes on antimicrobial resistance & new TB medicine development
💊Progress on TBAJ-587
🔍Novel drug testing approaches & mechanisms of action
@ihieurope.bsky.social @amr-accelerator.bsky.social @www.unizar.es
Lindsay Sonnenkalb from @fzborstel.bsky.social will be speaking on ‘New technologies for understanding drug resistance’. 25 minute slots will be available throughout the day.
➡️Book here: www.leibniz-gemeinschaft.de/ueber-uns/ne...
#Tuberculosis #TBResearch #TBSky
Lindsay Sonnenkalb from @fzborstel.bsky.social will be speaking on ‘New technologies for understanding drug resistance’. 25 minute slots will be available throughout the day.
➡️Book here: www.leibniz-gemeinschaft.de/ueber-uns/ne...
#Tuberculosis #TBResearch #TBSky
@pasteurlille.bsky.social at the #EMBOcellBioHostPath conference in Blois (France) presenting the ERA4TB host-pathogen interaction platform (BT08) and enjoying vivid discussions with TB experts in the field.
#TBSky #TBResearch
@pasteurlille.bsky.social at the #EMBOcellBioHostPath conference in Blois (France) presenting the ERA4TB host-pathogen interaction platform (BT08) and enjoying vivid discussions with TB experts in the field.
#TBSky #TBResearch
Thanks to our host, @www.unizar.es, all our partners, our key-note speakers and the Scientific Advisory Board members for their attendance and insightful contributions.
@pasteur.fr @amr-accelerator.bsky.social @ihieurope.bsky.social
Thanks to our host, @www.unizar.es, all our partners, our key-note speakers and the Scientific Advisory Board members for their attendance and insightful contributions.
@pasteur.fr @amr-accelerator.bsky.social @ihieurope.bsky.social